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‘Excitotoxicity’ represents the excitatory amino acid mediated degeneration of neurons. 
Glutamate is the major excitatory neurotransmitter in the brain. Glutamate excitotoxicity has 
been  implicated in a number of neurodegenerative disorders like Stroke, Epilepsy, Alzheimer’s 
disease and traumatic brain injury. This neurotoxicity is summed up by the ‘glutamate 
hypothesis’ which describes the cause of neuronal cell death as an excessive release of glutamate 
causing over excitation of the glutamate receptors and subsequent increase in influx of calcium 
leading to cell death. An effort to counteract this neurotoxicity has lead to the development of 
glutamate receptor antagonists that can effectively serve as neuroprotective agents. Nevertheless, 
the downside to these drugs has been the side effects observed in clinical trial patients due to 
their disruptive action on the physiological function of these receptors like learning and memory. 
 This work was undertaken to identify targets that can effectively be used to treat 
excitotoxicity without affecting any normal physiological functions. In one approach, (chapter I) 
we have identified the KATP channels as an effective modulator of epileptogenesis. In another 
approach, (Chapter II) we show that targeting the AMPA receptor subunit GluR2 is a practical 
strategy for stroke therapy.  
KATP channels that are gated by intracellular ATP/ADP concentrations are a unique 
subtype of potassium channels and play an essential role in coupling intracellular metabolic 
events to electrical activity. Opening of KATP channels during energy deficits in the central 
nervous system (CNS) induces efflux of potassium ions and in turn hyperpolarizes neurons. 
Thus, activation of KATP channels is thought to be able to counteract excitatory insults and 
protect against neuronal death. Here, we show that, functional Kir6.1 channels are located at 
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excitatory pre-synaptic terminals as a complex with type-1 Sulfonylurea receptors (SUR1) in the 
hippocampus. The mutant mice with deficiencies in expressing the Kir6.1 or the SUR1 gene are 
more vulnerable to generation of epileptic form of seizures, compared to wild-type controls. 
Whole-cell patch clamp recordings demonstrate that genetic deletion of the Kir6.1/SUR1 
channels enhances glutamate release at CA3 synapses. Hence, expression of functional 
Kir6.1/SUR1 channels inhibits seizure responses and possibly acts via limiting excitatory 
glutamate release.  
In addition to epilepsy, ischemic stroke is a leading cause of death in developed 
countries. A critical feature of this disease is a highly selective pattern of neuronal loss; certain 
identifiable subsets of neurons, particularly CA1 pyramidal neurons in the hippocampus are 
severely damaged, whereas others remain intact. A key step in this selective neuronal injury is 
Ca2+/Zn2+ entry into vulnerable neurons through α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid (AMPA) receptor channels, a principle subtype of glutamate receptors. AMPA 
receptor channels are assembled from glutamate receptor (GluR) -1, -2, -3, and -4 subunits. 
Circumstance data have indicated that the GluR2 subunits dictate Ca2+/Zn2+ permeability of 
AMPA receptor channels and gate injurious Ca2+/Zn2+ signals in vulnerable neurons. Here we 
show that ischemic insults induce toxic Ca2+ entry through AMPA receptors into vulnerable 
neurons by modification of GluR2 RNA editing. Thus, targeting of GluR2 subunit can be 
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CHAPTER I  
REGULATORY ROLE OF KATP CHANNELS IN SYNAPTIC  






Epilepsy is a neurological disease arising from severe seizure activity in the brain. It is a 
high-risk disease affecting  24 to 53 people per 100000 individuals in developed countries 1, 2. 
About 70% of the cases are idiopathic, meaning they have no clear underlying cause. The rest of 
the causes, range from genetic factors to head trauma or stroke.  Some of the types of epilepsy 
are childhood absence epilepsy, benign focal epilepsy, juvenile myoclonic epilepsy and temporal 
lobe epilepsy (TLE) 3. TLE is the most common form of epilepsy in adults. It arises due to 
seizure activity in the temporal lobes. It is further classified based on origin into Mesial TLE 
arising from the hippocampus, amygdala or the para hippocampal gyrus and Lateral TLE arising 
from the neocortex. Chronic TLE results in hippocampal sclerosis causing memory problems in 
adults and learning disabilities in children. It commonly manifests in a status epilepticus state or 
recurrent seizures, which might lead to brain damage. It is also very resistant to drugs and often 
requires surgical intervention. Although extensive research has been done using animal models 
to characterize this form of epilepsy, there are still huge gaps to be filled before an effective 
strategy is formed to combat this disease 4-7.  
Neuronal activity is a balance between the excitatory and inhibitory signals from the 
presynaptic termini. Thus, the uncontrolled firing during epileptogenesis is a result of decreased 
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GABA release from the pre-synaptic terminals and hence decreased inhibition or increased 
excitatory glutamate release leading to increased excitation and eventually excitotoxicity  8-11 .  
 
Excitatory glutamate synaptic transmission and neuronal degeneration 
 
Glutamate is the major excitatory transmitter in the mammalian central nervous system 
(CNS) and plays an essential role in neural development, excitatory synaptic transmission, and 
plasticity 12. On the other hand, glutamate mediated excitatory insults are implicated in a number 
of acute neurological disorders including stroke 13, 14 and traumatic brain injury 15 as well as in 
chronic neurological disorders such as multiple sclerosis, Huntington’s disease, Parkinson’s 
disease and Alzheimer’s disease 16.  In case of energy deficits (i.e., reduction of intracellular 
ATP concentration) however, glutamate accumulates in the synaptic cleft due to increased 
glutamate release from pre-synaptic termini and decreased glutamate uptake by the astrocytes 17, 
18. This results in extensive stimulation of the glutamate receptors and is eventually toxic to the 
neurons 12, 19. 
Glutamate activates three classes of ionophore-linked postsynaptic receptors, including 
N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
(AMPA) and kainate (KA) receptors 20, 21. Activation and opening of these channels causes an 
influx of cations and opening of Ca2+ channels 22. The subsequent influx of Ca2+ causes further 
glutamate release and initiates the process of neuronal cell loss. This phenomenon has been 































































Figure 1. Glutamate mediated excitotoxicity 
 
a) Glutamate is released spontaneously from presynaptic termini. They activate post-
synaptic receptors NMDA and AMPA. Activation of AMPA receptors makes them permeable to 
sodium ions that depolarize the cell.  Depolarization opens NMDA receptors that is permeable to 
calcium in addition to sodium. This calcium along with the calcium from the VDCC leads to 
further glutamate release. When the cell depolarizes, the potassium channels open and efflux 
positively charged potassium ions that hyperpolarizes the neuron. This brings the neuron back to 
the resting membrane potential. b) Increase in glutamate release from the pre-synaptic termini 
allows repeated neuronal excitation that causes the entry of lethal levels of Ca2+ and leads to 
glutamate excitotoxicity. 
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The NMDA receptors are made of a NR1 subunit combined to a regulatory subunit 
NR2A-D 24, 25 . They are a unique subtype of glutamate receptors since they are permeable to 
Ca2+ flow and their activation requires neuronal depolarization 26. This Ca2+ along with the Ca2+ 
from the VDCC leads to an overload that triggers several downstream lethal reactions including 
nitrosative stress, oxidative stress and mitochondrial dysfunction 16. AMPA receptors are made 
of GluR1-4 subunits. They are highly permeable to Na+ and K+ and are involved in excitotoxicity 
mediated cell death 27. Most AMPA receptors in the brain consist of a GluR2 subunit that makes 
them impermeable to Ca2+ 28, 29. However, GluR2-containing AMPA receptors are decreased 
during ischemia by down regulation of GluR2 mRNA expression and GluR2 RNA editing, 
leading to AMPA receptors permeable to Ca2+ 30-32. The KA receptors are made of the GluR5-7 
and KA1-2 subunits. Like AMPA receptors, the KA receptors mediate slow neuronal injury 33. In 
addition to ionophore-linked receptors, glutamate also activates metabotropic glutamate 
receptors (mGluRs), a large family of G-protein coupled receptors that modulate excitatory 
synaptic transmission through several signal transduction mechanisms 34, 35. Recent advances in 
the molecular biology, physiology and pharmacology of these receptors revealed their potential 
role in a variety of central nervous system disorders such as epilepsy, pain, ischemia, and 
neurodegenerative diseases 36-38.  
Excitation and generation of action potentials in a neuron also depends on a diverse array 
of ion-gated channels for Ca2+, Na+, and K+. The opening of the voltage gated K+ channels is a 
major component that causes repolarization of the cell to the resting potential. This property 
allows the neuron to curb calcium influx and thus decrease extensive glutamate release 39. Thus, 
activation of certain type of endogenous ion channels that are able to attenuate neuronal 
depolarization may produce neuronal protective effects. One such potential candidate is the 
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Potassium ATP channels (KATP channels). A reduction of intracellular ATP levels because of 
energy deficit activates KATP channels, thereby preventing membrane epolarization. Hence, the 
activation of KATP channels would be able to protect neurons from metabolic stress such as 
hypoxia and epilepsy.  
 
Molecular basis of KATP channels 
 
KATP channels are an octameric complex consisting of inwardly rectifying K+ channels 
(Kir6.1 and Kir6.2) and regulatory sulfonylurea receptors (SUR1, SUR2A and SUR2B), which 
are a member of the ATP-binding cassette (ABC) protein family (Figure 2), 40, 41. The Kir6.1 and 
Kir6.2 share 70% amino acid identity and the monomers have a pore loop domain flanked by 
two transmembrane segments (TM1 and TM2). The N and C-terminal domains are cytoplasmic 
and bind to ATP. A linker that connects TM1 to TM2 makes the channel selectively permeable 
to K+ ion flow 40, 42. Both the pore-forming subunits and the regulatory SUR receptors have ER 
retention motifs. In case of the Kir6.2 subunits, the ER retention motif is located at the C-
terminal between TM1 and NBF-1 domain. When it associates  with SUR1 the ER retention 




Figure 2. Schematic representation of the structural organization of KATP channels. 
 
 
There are different types of functional KATP channels based on the different combination 
of the Kir and SUR subunits in different cell types. The Kir6.2/SUR1 complex is the β-cell KATP 
channels, which controls insulin secretion in response to changes of blood glucose concentration 
a) KATP channels have two subunits, Kir and SUR. The Kir is made of two 
transmembrane domains TM1 and TM2 and a cytoplasmic domain with an inhibitory site for 
ATP binding. The SUR is composed of three transmembrane domains TMD0, TMD1 and 
TMD2. They are connected by the linker regions L0 and L1. The Nucleotide Binding domains 
(NBD1 and NBD2) that bind to ATP are cytoplasmic. They constitute the Walker motifs A and 
B. b) Heteromeric assembly of KATP channels where four Kir and four SUR subunits come 
together to form a functional channel. 
M1 M2





















45. The cardiac muscle, KATP channels consist of the Kir6.2 subunits and SUR2A receptors 46. 
The Kir6.1/SUR2B complex forms the vascular KATP channels and play critical roles in 
regulation of vascular tonus, especially in the coronary arteries 45. In contrast to peripheral 
tissues, neuronal KATP channels are less understood. To date, the only molecularly characterized 
KATP channel components expressed in the brain regions, including the hypothalamus 47, basal 
forebrain cholinergic neurons 48, and striatum 49, are thought to be the Kir6.2 types. Although 
pharmacological approaches suggest the presence of SUR1 receptors 50, their functional 
properties in the brain are yet to be fully characterized. Recently, we used electron microscopy 
(EM) combined with gene targeting approaches to study neuronal type KATP channels. Our 
results demonstrate that, as opposed to the Kir6.2 channels that are most likely to be at peri-
synaptic sites, in the hippocampus, functional Kir6.1 channels are predominantly located in the 
“active zone” of the pre-synaptic terminals that controls glutamate release 51. Consistent with 
these data, activation of KATP channels by channel openers reduces the release of several 
neurotransmitters, including excitatory glutamate 51, dopamine 49, 52, 53 as well as inhibitory γ-
aminobutyric acid (GABA) 49, 54.  
 
KATP channel function in pancreatic β cells 
 
KATP channel activity is regulated by nucleotides 55, 56. Binding of intracellular MgATP to 
either the SUR or Kir6.2 subunits activates and/or deactivates these channels 40, 57, 58. Opening of 
the KATP channel is also modulated by Phosphatidylinositol bisphosphate (PIP2) 59, 60 and by 
mutations of the Kir6.2 gene 55, 61, 62. The physiological function of the KATP channel has been 
extensively characterized in the pancreatic-β cell.  These channels are involved in the first phase 
of insulin secretion. At normal glucose levels, the KATP channel is active (open). The loss of K+ 
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maintains the cell at a hyperpolarized state. Increased blood glucose levels and subsequent 
metabolism increases intracellular ATP levels that inactivate (close) the channel (Figure 3). 
Subsequent depolarization opens voltage gated Ca2+ channels 44. Increase in intracellular Ca2+ 
concentrations triggers insulin release. As levels of glucose fall, the KATP channels in the 
glucose-responsive neurons in the hypothalamus are activated and this stimulates the pancreatic 























Figure 3. KATP channel activation is linked to the metabolic status of the cell. 
 
a)  In Pancreatic β-cells, increase in glucose, increases ATP levels. This keeps the 
channels inactive, depolarizing the cell and causing insulin granule release. In the brain, 
physiological ATP concentrations keep the channel inactive. b) However when the metabolism 
of the cell is compromised, like during an ischemic or epileptic episode, the levels of 
intracellular ATP drops and the KATP channels are activated. Their activation effluxes potassium 
ions and hyperpolarizes the cell. The loss of membrane potential blocks lethal Ca2+ entry. 
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Accordingly, KATP channel mutations are associated with many glucose-metabolism 
related disorders. Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI) or Congenital 
Hyperinsulinism (CHI) is an inherited disorder due to mutations on the SUR1 or the Kir6.2 genes 
64. Permanent Neonatal Diabetes Mellitus (PNDM) is another disease, which is often associated 
with mental retardation and epilepsy due to Kir6.2 mutations 65, 66. Mutations have been reported 
on the SUR1 subunit as well. Some of these mutations prevent trafficking of the channel to the 
plasma membrane and others prevent activation of the channel in response to elevated 
intracellular MgADP 67, 68. Invariably, all mutations on the KATP channels decrease insulin 
secretion and cause improper glucose metabolism 69, 70. SUR1 knockout mice also have 
diminished insulin release capabilities and hypoglycemia. Essentially, all these mice exhibit a 
diabetic phenotype 71.  
Several pharmacological compounds that serve as KATP channel openers or KATP channel 
blockers have been useful for characterizing the function of KATP channels 72. Diazoxide, 
cromakalim and pinacidil are major openers of the KATP channels 58. Importantly, diazoxide that 
has been prevalently used to treat insulin release related disorders 73 and is widely used to 
distinguish the SUR2A-containing KATP channels from the SUR2B; the SUR2B is sensitive 
while SUR2A is insensitive to diazoxide 74. Sulfonylureas including glibenclamide and 
tolbutamide serve as  KATP channels blockers and are clinically used for the treatment of diabetes 
75. In spite of the availability of these KATP channel blockers and openers, their lack of specificity 





Mitochondrial KATP channels 
 
In addition to the KATP channels on the cell surface, mitochondria have been found to 
have their own KATP channels (mitoKATP) on their inner membrane. Like the cell membrane KATP 
channels, they are also inhibited by ATP 76. Activation of mitoKATP has shown to exert various 
protective effects by reducing infarct size during ischemia, blocking cytochrome C release and 
increasing association of the anti apoptotic Bcl2 protein to the mitochondria 77. Their major 
contribution is protection from cell death as shown in ischemic preconditioning during cerebral 
and cardiac ischemia 78-80. Diazoxide opens the mitoKATP channels and 5-hydroxydecanoate 
blocks it making them widely used compounds to study these channels 72. The subunit 
composition of the mitoKATP is controversial because several groups have attempted to decipher 
their composition but with conflicting results 81, 82. This can be attributed to the use of different 
antibodies raised against different epitopes and their lack of specificity. Research is also 
hampered by the lack of specific pharmacological tools that would allow for the functional 
characterization of  mitoKATP and cell membrane KATP channels 72. 
One direct effect of excitatory glutamate toxicity is mitochondrial dysfunction 83, 84. 
Increase in cytoplasmic Ca2+ through the activation of NMDA (N-methyl-D-aspartate) subtype 
glutamate receptors results in Ca2+ flow into the mitochondria through the Na-Ca uniporter 85. As 
the mitochondrial matrix is depolarized the mitochondrial oxidative phosphorylation is impaired, 
leading to ATP depletion 86. The swelling of the mitochondria results in membrane rupture and 
release of pro-apoptotic proteins 87, 88. In addition to extra cellular Ca2+, mitochondrial stores 
released Ca2+ is also responsible for the intracellular Ca2+ overloading and neuronal cell death 89, 
90. Recent studies have shown that activation of mitoKATP during ischemia reduced Ca2+ 
accumulation in the heart mitochondria 91. Activation of mitoKATP by diazoxide has also been 
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linked to a hyperpolarization in the mitochondria and decreased Ca2+ influx 92, 93. Given that 
accumulation of Ca2+ in the mitochondria also induces reactive oxygen species (ROS)-related 
neuronal death 94-96, it is reasonable to speculate that neuronal protection can be achieved by 
activation of mitoKATP channels during excitotoxic injury.  
 
KATP channels in glutamate mediated synaptic degeneration  
 
Anoxia-hypoxia depletes cellular oxygen levels and induces anoxic depolarization. This 
opens several voltage-gated channels leading to a massive overload of Na+ and Ca2+ ions 
disrupting cellular functions and eventually leading to cell death 97, 98. Activating KATP channels 
in this case will cause anoxic hyperpolarization and dampen the depolarization-induced 
glutamate excitotoxicity protecting neuronal cells 99. Several investigators have addressed this 
issue. For instance, Protein Kinase G (PKG) activates KATP channels by phosphorylation of 
serine threonine residues. This contributes to anoxic preconditioning (APC) and was shown to 
reduce anoxia/reperfusion induced cardiac damage in rat hearts 100. It has also been shown that 
zinc protects from ischemic damage of the hippocampus by inhibiting glutamate release from 
mossy fiber synaptosomes. This was observed when micro molar concentrations of zinc opened 
KATP channels during anoxic-hypoglycemic episodes  101.  
Recent studies using the null mutant mice lacking the Kir6.2 gene (Kir6.2-/-) indicate that 
the most Kir6.2-/- mice die, whereas all wild-type control mice survive from 15-min occlusion of 
the middle cerebral artery occlusion (MCAO). Although poor survival of these Kir6.2-/- mice 
could be due to the surgical procedures but not due to the brain damage [a very small infarction 
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size (11.67 ± 1.28 mm3) was observed in these mice] 102, it is generally agreed that expression of 
KATP channels protects against neuronal injury from ischemic insults 45, 99.  
In addition to ischemic neuronal death, respiratory arrest can induce epileptic activity, 
which coupled with increased metabolism of the available cerebral oxygen decreases cellular 
ATP levels and lead to activation of KATP channels. Increased efflux of K+ ions mediated by 
these activated channels causes neuronal hyperpolarization that suppresses the epileptic 
responses 103, 104. Indeed the Kir6.2-/- mice exhibit an increased susceptibility to seizures after 
hypoxia 105. This can be explained because of the inwardly rectifying nature of the Kir subunit. 
The subunit helps in hyperpolarizing the membrane following a depolarization and helps control 
excitability.  Conversely, over expression of SUR1 in mice makes them more resistant to 
generation of seizures 106. The regulatory nature of the SUR1 subunits probably helps to keep the 
channel in an active state and thus preventing epileptogenesis. 
The Substantia Nigra pars Reticulata (SNr) is a major brain region that controls the 
propagation of seizures. It also has the highest expression of KATP channels especially the 
pancreatic β-cell type (Kir6.2/SUR1) 105. As the SNr neurons are the central gating system from 
where seizures propagate, the KATP channels in the SNr will be the first line of defense against 
the propagation of seizures caused by ATP depleted conditions such as hypoxia and 
hypoglycemia. As expected, the firing rate of SNr neurons of Kir6.2-/- mice was 1.8 fold higher 
compared to the wild type. This effect was reversed by tolbutamide, a sulfonylurea that inhibits 
KATP channels 107. It should be noted here that, the specificity of tolbutamide depends on the 
availability of Mg2+ and KATP channel subunit composition 75, 108. Previous studies showed that 
hypoxic insults activate KATP channels and in turn suppress epileptic activity in the Substantia 
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Nigra neurons 105. Thus, the ability of the KATP channels to sense the metabolic state of the cell 
will help reverse the cell damage by reducing membrane excitability. 
 Kainic acid (KA) is a glutamate analog that serves as an agonist for AMPA/KA 
receptors 9. Activation of these receptors leads to a series of intracellular events including Ca2+ 
influx, Reactive Oxygen Species (ROS) production, increased Nitric Oxide Synthase (NOS) 
levels, membrane depolarization, mitochondrial dysfunction and apoptosis 19. KA-induced status 
epilepticus causes delayed and specific neuronal death in the pyramidal neurons of the CA3 and 
CA1 areas of the hippocampus neurons 9, 109. This cell death is mainly by the excitation of 
AMPA type glutamate receptors, which as noted earlier are impervious to Ca2+ 28, 29. 
Nevertheless, it has been observed that there is a reduction in the GluR2 mRNA expression 
preceding cell death. Down regulation of GluR2 mRNA facilitates AMPA mediated Ca2+ entry 
into CA3 pyramidal neurons and causing neuronal death 19, 30, 31, 110. The epileptic activity in the 
CA3 is also largely generated by the GluR6 receptors 111. 
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Hypothesis 
 KATP channels regulate NMDA receptor function  
 
Glutamate excitotoxicity is a major cause of neuronal cell death during ischemia and 
seizures. Glutamate is released from pre-synaptic terminals and activates postsynaptic glutamate 
receptors like NMDA, AMPA and KA 20, 21. Over-stimulation of NMDA receptors due to 
glutamate accumulation is lethal as these receptors are permeable to toxic Ca2+ ions 112. Hence, 
mechanisms that counteract this phenomenon play an essential part in neuronal protection. The 
ability of the KATP channels to activate and hyperpolarize the cell in response to a drop in ATP 
levels places them at a unique position to sense and modulate the activation of glutamate 
receptors (particularly, NMDA receptors, a principle subtype of glutamate receptors, since they 
are activated only if membrane potentials are depolarized). Accordingly, activation of KATP 
channels will induce neuronal hyperpolarization, prevent NMDA receptor channel opening, and 
hence protect from hypoxic/ischemic insults and epileptogenesis (Figure 4).  
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Figure 4.  Activation of KATP channels counteracts glutamate toxicity.  
 
a) KATP channels are inactive. Hypoxic/ischemia depolarizes neuronal terminals and leads
Ca2+ influx through voltage-gated Ca2+ channels (VDCC). Ca2+ entry triggers glutamate release 
that activates postsynaptic glutamate receptors including NMDA and AMPA receptors. Over-
stimulation of NMDA and AMPA receptors leads to Ca2+ overloading in the post-synaptic 
neurons, resulting in neuronal death. b) KATP channels are activated. Hypoxic/ischemia also 
activates KATP channels and in turn hyperpolarizes neuronal terminals. Neuronal hyper-
polarization inactivates VDCC and in turn terminates Ca2+-dependent glutamate release, thereby 
protecting against ischemic insults. 
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Cortical neurons were cultured from P1 pups. The brains were dissected onto HBSS. The 
meninges were removed and the cortices were extracted. The tissue was digested with trypsin at 
37°C for 15 minutes. The enzyme was inactivated with horse serum and spun at 1000rpm, 5 
minutes at  22°C. The pellet was triturated 10 times with a fire polished Pasture pipette. The cell 
suspension was spun at 1000rpm, 5 minutes at 22°C to pellet the neurons. The cells were 
resuspended in Neurobasal medium supplemented with B27, 0.5mM Glutamax, PSN, 25µM 
Glutamate and plated at a concentration of 1 X 105 per well. The neurons were then maintained 
in feeding medium (Neurobasal medium supplemented with B27, 0.5mM Glutamax and PSN) 
until treatment at 37°C, 5% CO2. 
 
Stable Kir6.1 gene silencing and virus  infection 
 
Kir6.1 siRNA (KsiRNA) sequence (forward: 5′-GGUGAAUGGCCAGGUUUUUtt-3′; 
reverse: 5′-AAAAACCUGGCCAUUCACCtc-3′) was provided by Ambion, Inc. (Austin, TX) 
and synthesized as two cDNA oligonucleotides, which were cloned in pSilencer-U6 through 
BbsI/BstB sites, as described before 31, 32, 113. The U6-KsiRNA cassette was re-cloned into 
rAVETM construct containing eGFP through ApaI/KpnI (GenDetect, New Zealand), creating a 
vector rAVE-U6/KsiRNA-CAP/eGFP. A control vector was used to express a scrambled 
KsiRNA (rAVE-U6/SKsiRNA-CAP/eGFP). The rAVE plasmids were co-transfected with the 
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AAV helper 2 into HEK293 cells to generate the rAAV2 virus particles. The high titer infectious 
virus particles were purified and calculated by GenDetect Inc. (New Zealand). The infectious 
particles were then perfused (2 µl at 0.2 µl/min) into each side of the hippocampus (2.1 mm 
posterior to bregma; 1.9 mm lateral to the midline; 2.6 mm below dura) of mice, as previously 








AAV helper 2 virus
Hippocampal injection  
Figure 5. Flowchart representing the construction of Kir 6.1 SiRNA in an Adeno virus 





RT-PCR analysis  
 
RNA was isolated from the hippocampus of mice without or with infection of the virus 
particles and treated with the DNA-freeTM kit (Ambion), as described before 31. Sample aliquots 
containing 25 µg RNA were incubated for 30 min at 37°C with 2 IU DNase I in DNase reaction 
buffer [10 mM Tris–Cl (pH 7.5), 2.5 mM MgCl2, 0.1 mM CaCl2] in a total volume of 50 µl. The 
reaction was stopped by addition of 5 µl resuspended DNase Inactivation Reagent and incubation 
at room temperature for 2 min. This reagent, as well as the DNase I and divalent cations, were 
removed by centrifugation at 10000xg for 1 min. DNase I-treated RNA samples were reverse-
transcribed in a 20 µl reaction volume containing 50 mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM 
MgCl2, 10 mM dithiothreitol, 500 ng oligo(dT)15  primer and 200 IU M-MLV reverse 
transcriptase (Promega, Madison, WI) for 1 hr at 42°C. Control samples, where no reverse 
transcriptase was added, were included in all experiments to show that all products were RNA-
derived and not the result of genomic DNA contamination. PCR amplification was carried out 
with 5 µl cDNA product in a 50 µl reaction volume containing 20 pmol of each specific 
oligonucleotide primers: Kir6.1 nucleotides 277-615 (accession no. NM-008428) forward: 5’-
AAAGGAAGATGTTGGCCAGGAA-3’,  reverse: 5’-CCATGGTGCCTTTCTCCATGTA-3’, 
50 nmol/l dNTP, 1.25 IU Taq DNA Polymerase (5 IU/µl) (Roche Diagnostics, Mannheim, 
Germany) in 10 mM Tris–HCl, 1.5 mM MgCl2, 50 mM KCl (pH 8.3). After an initial pre-heat at 
95°C, PCR amplification was carried out for 22 to 45 cycles of denaturation at 95°C (20 s), 
annealing at 52°C (45 s), and extension at 72°C (1 min), followed by a final extension at 72°C 
for 10 min. The number of cycles used was limited to ensure product amplification remained in 
the log-linear range. ß-actin was adopted as a control. PCR products were separated by 
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electrophoresis on a 1.5% agarose gel and visualized after ethidium bromide staining over UV 
light. 
 
Electron microscopy  
 
The post-embedding immuno-gold method has been described 114, 115. In this study, 
sections from the CA1 stratum radiatum of the hippocampus of 3 male Sprague−Dawley rats (37 
days old). Rats were perfused with 4% paraformaldehyde plus 0.5% glutaraldehyde in 0.12 M 
phosphate buffer. Parasagittal sections (250 µm) of the hippocampus were cryoprotected in 30% 
glycerol and frozen in liquid propane in a Leica EM CPC. Frozen sections were immersed in 
1.5% uranyl acetate in methanol at −90°C in a Leica AFS freeze−substitution instrument, 
infiltrated with Lowicryl HM-20 resin at −45°C, and polymerized with ultraviolet light. Thin 
sections of the hippocampus were incubated in 0.1% sodium borohydride plus 50 mM glycine in 
Tris−buffered saline/0.1% Triton X−100 (TBST), followed by 10% normal serum (NS) in TBST. 
One set of the experiments were done using a 10-day old rat, anti-Kir6.1 (1:300) and anti-Kir6.2 
(1:300) antibodies were provided by Dr Andrew Tinker (University College London, London, 
UK). Another set of the experiments were done on three adult rats, using anti-rabbit Kir6.1 
antibody (1:80) purchased from Sigma (P0874) and anti-goat Kir6.2 antibody (10 µg/ml) 
purchased from Santa Cruz (SC-11226). The antibodies were prepared in 1% NS/TBST and 
10nm immunogold was prepared in 1% NS/TBST plus 0.5% polyethylene glycol, and finally the 
sections were stained with uranyl acetate and lead citrate. The anti-Kir6.1 antibody was raised in 
rabbits against a peptide corresponding amino acids 399-RRNNSSLMVPKVQFMTPEGNQC-
420) and anti-Kir6.2 was raised in goats against Kir6.2 peptide corresponding amino acid 357-
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372. For quantification of random areas of the CA1 stratum radiatum from the 3 P37 rats, all 
spine synapses with gold labeling within 20 nm of the cell membrane of the presynaptic terminal 
and the postsynaptic spine were photographed and counted. The membrane was divided into 6 
regions including the synaptic (=active zone), perisynaptic (=100 nm on either side of the active 
zone), and extrasynaptic membrane of both the presynaptic terminal and the postsynaptic spine 
membrane. A total of 56 synapses for Kir6.1 and 59 synapses for Kir6.2 were counted from the 3 
animals. Statistical analysis used a two-tailed t-test. 
 
Kainate administration  
 
Adult male mice (90 ± 5 days old of age, 28 ± 2 mg body weight) were intraperitoneally 
injected with kainic acid (30 mg/kg in PBS, A. G. Scientific Inc., San Diego, CA). Mice were 
monitored continuously for 3 hrs. The severity of seizures was rated by the arbitrary scale: 1: 
staring and immobility/wet dog shake; 2: hyperactivity, repetitive movements, rearing and 
falling; 3: low seizures (intense shivering); 4: severe tonic/clonic convulsion; 5: death. The 




Synaptosomes were generated as described before 31, 32, 113. Briefly, the hippocampal 
homogenate in 0.32 M sucrose was centrifuged for 10 min at 1,400g to yield a pellet (P1) and a 
supernatant (S1). S1 was further centrifuged for 10 min at 13,800g, yielding a crude 
synaptosomal pellet (P2) and a supernatant (S2). P2 was resuspended in 0.32 M sucrose 
containing 1 mM NaHCO3 and layered on top of a discontinuous sucrose gradient (0.8, 1.0 and 
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1.2 M). After centrifugation for 2 h at 82,500g, the synaptosomes were recovered as a band, 
resuspended in 0.32 M sucrose and 1 mM NaHCO3 plus protease inhibitors, pelleted and 
resuspended in HEPES buffer containing protease inhibitors.  
Synaptosomes were incubated with 1% Triton X-100 for 20 min on ice and centrifuged at 
14,000g for 15 mins to obtain the supernatant. Protein concentration in the extracts was 
determined by Lowry assay (Bio-Rad). The extracts (~500µg protein) were incubated with 
polyclonal rabbit anti-SUR1 (2 µg) overnight at 4°C, followed by the addition of 40 µl of Protein 
G-Sepharose (Sigma) for 3 hr at 4°C. Immunoprecipitates were washed four times with PBS 
buffer, denatured with SDS sample buffer, separated by SDS-PAGE and blotted with anti-Kir6.1 
(Santa Cruz, 1:100), anti-SUR1, or anti-syntaxin-1A (Santa Cruz, 1:400) antibodies. Anti-SUR1 
antibody was raised in a rabbit against the synthetic peptide CKRGAILEFDKPEKL (Sigma). 




Hippocampal slices (250 µm) were prepared from mice, as described before 31, 32, 113. 
Slices in the recording chamber were continuously superfused with artificial cerebrospinal fluid 
(ACSF, 2 ml/min) saturated with 95% O2/5% CO2 at 30°C ± 1°C. The composition of ACSF was 
124 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 1.2 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, 
and 10 mM dextrose. For whole-cell patch-clamp recordings (tight seal >15-25 GΩ) from CA3 
pyramidal cells, hippocampal slices were visualized with IR-DIC optics with an Axioskop 2FS 
equipped with Hamamatsu C2400-07E optics. The spontaneous EPSCs were recorded at a 
holding potential of -70 mV. The intracellular solution contained 142.5 mM Cs-gluconate, 7.5 
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mM CsCl, 10 mM HEPES, 0.2 mM EGTA, 2 mM Mg-ATP, 0.3 mM guanosine triphosphate (pH 
7.4; 296 mOsm). The currents were filtered at 5 kHz with a low-pass filter. Data were digitized 
at a frequency of 10 kHz and stored online with the pclamp11 system (Axon Instruments, Inc., 
Foster, CA). The input resistance and series resistance in postsynaptic pyramidal cells were 
monitored with prevoltage steps (−2 mV; 100 ms) at 5 min intervals throughout the period of the 
experiment. Series resistance ranged from 11 to 17 MΩ. Input resistance was 346 ± 18 MΩ. 
 
Treatment of cortical neurons with glutamate receptor antagonists 
 
Primary cortical neurons on DIV14 were washed twice with Neurobasal medium and 
treated with the following  
i) vehicle  
ii) 400µM Kainic acid + 10µM MK-801 + 10µM CNQX  
iii) 400µM Kainic acid  
iv) 500µM glutamate + 10µM MK-801 and  
v) 500µM glutamate  
in Neurobasal for one hour. At the end of treatment the cells were washed 4X with complete 
Neurobasal medium and let to recover in feeding medium (Neurobasal medium supplemented 
with B27, 0.5mM Glutamax and PSN) for 5 hrs at 37°C, 5% CO2.  The medium was recovered to 




LDH release assay 
 
The LDH release assay was carried out according to the manufacturer’s protocol 
(Promega cytotox 96 Non-radioactive cytotoxicity assay kit). Briefly, 50µl of the medium was 
mixed with 50µl of freshly reconstituted substrate in a 96 well plate. The plate was incubated in 
the dark for 30 minutes at 22°C. The reaction was terminated with 50µl of stop solution and the 
absorbance was read at 490nm. The average LDH release was calculated from 4 independent 
experiments. The value was expressed as a percentage of LDH release normalized over 
glutamate mediated cell death (treatment v) using the formula  
% Cell death = [(absorbance treatment – absorbance control) X 100] / [absorbance 
glutamate]. 
 
Propidium iodide staining 
 
The cells were washed three times with Hanks Balanced Salt solution (HBSS) to remove 
the culture medium. They were stained with  Propidium iodide (PI) (3µM) in HBSS for 20 
minutes at 37°C, 5% CO2 followed by 4X wash with HBSS. The stained cells were fixed with 
4% para formaldehyde in PBS pH 7.4 at 22°C for one hour. The cover slips were then mounted 
on glass slides using DPX Fluor mounting medium. The pictures were taken with a Carl Zeiss 
Apotome microscope. The number of PI positive cells were counted manually and expressed as a 





The Kir6.1 and Kir6.2 proteins are common at excitatory synapses 
 
We first examined the expression of KATP channels in the hippocampus by immuno-gold 
labeling of the Kir6.1 (Fig. 6a) and Kir6.2 (Fig. 6b) subunits. Overall, the labeling shows that 
both Kir6.1 and Kir6.2 proteins are found on synaptic membranes of terminals and spines as well 
as in vesicular structures within the synaptic cytoplasm. 
 






Representative micrographs showing immunogold labeling of the Kir6.1 (a) and the
Kir6.2 (b) Proteins associated with synapses in the adult rat hippocampus. Arrows indicate the 
labeling in the pre-synaptic (a) and pre-perisynaptic (b) membrane. 
 25
By comparing the labeling patterns between Kir6.1 and Kir6.2 proteins, we found that the 
Kir6.1 subunits were located predominantly in the presynaptic membrane (active zone), whereas 
Kir6.2 subunit was most likely to be located in the perisynaptic area of the terminals (Fig. 7a and 
7b). These findings indicate that Kir6.1 proteins in the presynaptic terminal are concentrated 









a) Bar graph summarizes the gold/synapse for the Kir6.1 (filled bars) and the Kir6.2 
(open bars) labeling in pre-synaptic (pre-syn), pre-perisynaptic (pre-peri), pre-extrasynaptic (pre-
extra), post-synaptic (post-syn), post-perisynaptic (post-peri) and post-extrasynaptic (post-extra) 
membrane. Data are mean ± SEM (*p < 0.01). The left asterisk indicates the difference between 
Kir6.1 pre-synaptic and pre-peri-synaptic (p < 0.01); and the right asterisk indicates the 
difference between Kir6.2 and Kir6.1 pre-perisynaptic (p < 0.05). b) Bar graph shows a 
percentage of total membrane gold for the Kir6.1 (filled bars) and the Kir6.2 (open bars). Data in 
(a) and (b) are mean from three 37 days old mice. 
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Generation of the Kir6.1 stable gene silencing in the hippocampus of adult mice  
 
We next determined the potential functions of the synaptic KATP channels in the 
hippocampus. We generated stable Kir6.1 gene silencing using small interfering RNA (siRNA) 
that specifically targets to the Kir6.1 gene (KsiRNA). The KsiRNA was expressed in the 
hippocampus of adult mice using the rAAV2-KsiRNA-eGFP vectors (Fig. 8) 
 
Figure 8. Inhibition of the Kir6.1 gene expression in the hippocampus 
 
 
Expression of a scrambled KsiRNA (SKsiRNA, rAAV2-SKsiRNA-eGFP vector) was 
used as control. The Fluorescence images show that neurons expressing a reporter gene (eGFP) 
were present throughout the hippocampus 12 days after infection with the rAAV2 virus particles. 
A reduction of the Kir6.1 mRNA levels was detectable 6 days after infection with the rAAV2-
KsiRNA-eGFP, and the maximum inhibition of the Kir6.1 mRNA (Fig. 9a and  b, 76.9 ± 5.3%, n 
The representative images of the hippocampus (left) expressing the KsiRNA and eGFP 
were taken 12 days after injection of the infectious rAAV2-ksiRNA-eGFP virus particles. Higher 
magnifications show the CA3 area of the hippocampus (middle) and pyramidal neurons (right). 
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= 6 assay/3 mice) was observed 6 days later (12 days after virus infection), demonstrating a 




Figure 9. KSiRNA effectively downregulates Kir6.1 mRNA levels  
 
 
Silencing Kir6.1 gene increases the susceptibility of mice to KA-induced seizures  
 
Subsequently, we analyzed the susceptibility of adult mice with Kir6.1 gene silencing to 
kainic acid (KA)-induced seizures, which are widely considered to be an animal model of human 
temporal lobe epilepsy and are associated with hyper-excitation in some subsets of neurons in the 
hippocampus 9. Mice were injected with KA (30 mg/kg, i.p.) 12 days after infection with the 
rAAV2-KsiRNA-eGFP (KsiRNA mice) or the control rAAV2-SKsiRNA-eGFP (SKsiRNA 
mice) virus particles. The latency and severity of seizures were then diagnosed and expressed as 
a) RT-PCR analysis shows the Kir6.1 mRNA in the hippocampus of mice 6 days or 12 
days after without (control) or with infection of the rAAV2-sksiRNA-eGFP (lane 1) or the 
rAAV2-ksiRNA-eGFP (lane 2) virus particles. b) Bar graph shows the Kir6.2 mRNA levels that 
were normalized to β-actin in their respective conditions. Data are mean ± SEM (* p < 0.01).  
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seizure index. Our data, as summarized in Table 1, show that all the KsiRNA mice suffered 
severe seizures including hyperactivity, constant rearing and falling. 7 of 10 KsiRNA mice had 
tonic convulsion and died within 3 hr (seizure index = 4.4 ± 0.31, n = 10). In contrast, the 
majority of the SKsiRNA mice showed no hyperactive responses and remained alive throughout 
the course of observation (seizure index = 2.56 ± 0.34, n =10).  
 




Experimental Groups No. of mice dead
(% mortality) 
Seizure Index 
(mean ± SEM) 
Latency (min) 
(mean ± SEM) 
SKsiRNA 2/10 (20%) 2.56 ± 0.34 30.1 ± 1.1 
KsiRNA 7/10 (70%) 4.40 ± 0.31* 34.5 ± 3.7 
 
To determine the functional partners of the Kir6.1 channels in the hippocampus, we 
precipitated the Kir6.1 protein complex in synaptosomes. Western blot analysis demonstrated the 
presence of the SUR1 proteins in the precipitates, indicating that the Kir6.1 subunits form a 
complex with SUR1 receptors. In addition to SUR1, we also found Syntaxin 1A, one of the 
SNARE proteins that participate in transmitter release, in the Kir6.1 protein complex (Fig. 10). 
These results confirm the labeling of functional Kir6.1/SUR1 channels at pre-synaptic terminals.  
 
The SKsiRNA and KsiRNA represent the mice that were intra-hippocampally injected 
with the rAAV2-SKsiRNA-eGFP or the rAAV2-KsiRNA-eGFP virus particles, respectively. 
The Kir6.1 silenced mice show increased susceptibility to kainic acid induced epileptogenesis 
and exhibit higher mortality rates compared to the control, scrambled SiRNA injected mice. *p < 
0.01, compared to controls. 
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Figure 10. The Kir6.1 is physically associated with SUR1 proteins. 
 
 
The null mutant mice lacking the SUR1 gene are vulnerable to KA-induced 
seizures  
 
Accordingly, we examined the seizure vulnerability of the null mutant mice lacking the 
SUR1 gene (SUR1-/-). We found that 8 of 11 SUR1-/- mice revealed tonic and clonic convulsion 
and died within 3 hr after seizure induction (seizure index = 4.73 ± 0.14), whereas most wild-
type control (SUR1+/+) mice survived (seizure index = 1.73± 0.36, n = 11, Table 2) and did not 
exhibit severe seizures. In addition to Kir6.1, the Kir6.2 subunits also form function channels 
with SUR1 receptors in the pancreatic β-cells 45 and possible in some subsets of neurons in the 
Endogenous Kir6.1 and SUR1 proteins in synaptosomes from adult mouse hippocampus 
were precipitated with nonspecific IgG or anti-SUR1, and blotted with anti-Kir6.1, anti-SUR1, or 
anti-syntaxin-1A, as indicated. In the lane marked input, 50 µg of proteins without 
immunoprecipitation was loaded. Similar results were observed in four independent experiments. 
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brain 47-49, 105. We found, however, that the mutant mice lacking the Kir6.2 gene (Kir6.2-/-, 
seizure index = 2.56 ± 0.34, n =12, Table 1) did not show a difference in the latency and severity 
of seizures compared with that of wild-type control (Kir6.2+/+) mice (seizure index = 1.73 ± 0.36, 
p > 0.01, n = 11, Table 2). Together, these results demonstrate a crucial inhibitory role of the 
Kir6.1/SUR1, but not of the Kir6.2 channels, in generation of hippocampus-dependent epileptic 
form of seizures. 
 




Experimental Groups No. of mice dead 
(% mortality) 
Seizure Index 
(mean ± SEM) 
Latency (min) 
(mean ± SEM) 
Controls 1/11 (9.1%) 1.73 ± 0.36 aN/A 
SUR1-/- 8/11 (73%) 4.73 ± 0.14* 32.3 ± 2.0 







Controls are wild-type C57BL/6 mice. The SUR1-/- mice show increased susceptibility to 
kainic acid induced epileptogenesis and exhibit higher mortality rates compared to wild type 
controls as well as the Kir6.2-/- mice. aData are not available since only one mouse in this group 
suffered seizures within 3 hrs after treatment of KA. *p < 0.01, compared to controls. 
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Enhanced glutamate release in neurons lacking the Kir6.1 channels  
 
Generation of epileptic form of seizures largely results from release of excitatory 
glutamate transmitter at CA3 synapses in the hippocampus 9. Given that the Kir6.1 proteins are 
found to be located at pre-synaptic terminals, we hypothesized that the neurons lacking the 
Kir6.1 channels may have enhanced release of glutamate transmitter for the induction of 
seizures. To test this hypothesis directly, we recorded the spontaneous excitatory postsynaptic 
currents (sEPSCs) from CA3 pyramidal neurons in the hippocampus of the KsiRNA (Fig. 11a) 
and the KSsiRNA mice (Fig 11b). The frequency of the sEPSCs onsets during KA application in 
the KsiRNA mice (2.12 ± 0.23 Hz, mean ± SEM, n = 12/recordings/4 mice Fig. 11c) were 
increased, compared to the KSsiRNA mice (1.23 ± 0.21 Hz, mean ± SEM, n = 12/recordings/4 
mice). The mean amplitudes were statistically identical between groups (Fig. 11d). 
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Figure 11. Inhibition of Kir6.1 gene expression enhances KA-induced glutamate release at 
CA3 synapses. 
 
(a-d) The traces are representatives of the spontaneous EPSCsAMPA recorded at holding 
potential of -70 mV from CA3 pyramidal neurons in the hippocampus expressing scrambled 
siRNA (SsiRNA, a) or the Kir6.1 siRNA (KsiRNA, b). Horizontal bar above the traces indicates 
kainate application. Bar graphs summarize the frequency (c) of the EPSCsAMPA onset and the 
mean amplitudes of the EPSCsAMPA (d). Data are mean ± SEM (n = 12 recordings/4 mice/group, 
*P < 0.01). 
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Enhanced glutamate release in neurons lacking the SUR1 subunits  
 
Following our data the SUR1 seems to be the regulatory component of the Kir6.1 
containing KATP channels in the hippocampus. Therefore, we hypothesized that their absence 
might also increase glutamate release from pre synaptic terminals. Therefore, we recorded the 
sEPSCs in CA3 pyramidal neurons from the SUR1-/- and the Kir6.2-/- mice (Fig. 12a). In this line 
of the experiments, the sEPSCs variability was estimated. The distribution of the sEPSCs at the 
baseline had clearly distinguishable peaks, and was fitted by the sum of multiple Gaussian 
functions (Fig. 12a). The frequency of sEPSCs was increased following application of KA, 
whereas the mean amplitude was unchanged (Fig. 12c). By comparison of the recordings 
between CA3 pyramidal neurons from the SUR1-/- and wild-type control mice, our results 
indicate that genetic deletion of SUR1/Kir6.1 channels increases glutamate transmitter release at 




Figure 12. Kainate increases glutamate release at CA3 synapses in the hippocampus. 
 
  
Kainic acid induced cell death is higher in SUR1-/- mice 
 
Our observations along with others have shown that although C57BL/6 mice undergo 
epileptic seizures on treatment with kainic acid, they do not show any neuronal cell death in vivo. 
To test this effect in vitro we treated primary cortical neurons from wild type controls, SUR1-/- 
and Kir6.2-/- mice with kainic acid (Figure 13). The cell death in these neurons was measured in 
terms of the LDH released. The KATP channel deficient neurons treated with kainic acid showed 
increased susceptibility to cell death as compared to wild type controls. This susceptibility was 
completely abolished in all genotypes when the glutamate receptor activation was blocked with 
specific blockers MK-801 (NMDA) and CNQX (AMPA). This shows that the kainic acid 
mediated excitotoxicity is mediated by glutamate activating postsynaptic glutamate receptors. It 
also shows that this excitotoxicity can be effectively counteracted by functional KATP channels.  
(a) Representative traces are from whole-cell patch clamp recordings of spontaneous 
EPSCs at holding potentials of -70 mV from CA3 pyramidal neurons in the hippocampus from 
wild-type controls (n = 14 cells/10 mice), or the Kir6.2-/- (n = 12 cells/7 mice) or the SUR1-/- (n = 
15 cells/7 mice) mice. Averaged spontaneous EPSCs before and during KA are shown in the 
right. Horizontal bar above the traces indicates kainate application. Note that kainate produced 
depolarizing currents (arrows) in the CA3 pyramidal neurons, but the mean amplitudes of the 
currents were no difference among groups. (b) Amplitude distribution histograms for the 
spontaneous EPSCs before (top) and during (bottom) KA are plotted with bin sizes of 4 pA. (c) 
The frequency but not the mean amplitude is increased at CA3 synapses in the hippocampus 







































We observed similar results when kainic acid treated neurons were stained with 
Propidium Iodide (PI) (Figure 14). The SUR1-/- and Kir6.2-/- neurons showed increased PI 
staining compared to the wild type controls.  
Cortical neuron cultures (DIV14) from wild type, Kir6.2-/-, and SUR1-/- mice were 
exposed to 400 µM kainic acid (KA) for one hour. Neuronal cell death was calculated by 
measuring the efflux of LDH 6 hrs later. Data is expressed as % LDH release by KA normalized 
to 500µM glutamate treatment (defined as 100%). Cultures from SUR-/- mice show increased 
neuronal cell death compared to wild type cultures (*p < 0.005, n = 4). This data is in 
concordance with the observations that absence of functional KATP channels increases glutamate 
receptor mediated excitotoxicity.  
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Cortical neuron cultures (DIV14) from wild type, Kir6.1-/-, and SUR1-/- mice were 
exposed to 400 µM kainic acid (KA) for one hour. a) Representative pictures of PI staining to 
show increased staining in SUR1-/- cultures compared to wild type controls. b) Neuronal cell 
death was quantified by counting PI positive cells. Data is expressed as percentage of PI positive 
cells over total number of cells. Cultures from SUR-/- and Kir6.2-/- mice show increased neuronal 





 This study has identified for the first time the presence of Kir6.1 subunit in the active 
zone of the pre-synaptic terminal. 
 This study also places Kir6.1/SUR1 type KATP channels and Syntaxin 1A in the same 
complex demonstrating their function in glutamate vesicle release. 
 This data also means that Kir6.1 and SUR1 constitute the functional KATP channels in the 
active zone. 
 Accordingly, Kir6.1/SUR1 type KATP channels in the hippocampus can block glutamate 
release thus curbing epileptogenesis. 
 Finally, the results show that KATP channel deficient mice are more prone to neuronal cell 




To date, the only molecularly characterized KATP channel components expressed in the 
brain regions including the hypothalamus 47, basal forebrain cholinergic neurons 48, and striatum 
49, is the Kir6.2 subunits, which are thought to protect against hypoxic insults. Although 
pharmacological approaches suggest the presence of SUR1 receptors 116, their functional 
properties in the brain have yet to be fully characterized. In the present study, we used electron 
microscopy combined with gene targeting studies. Our results clearly demonstrate that, as 
opposed to the Kir6.2-containing channels, functional KATP channels at pre-synaptic terminals in 
the hippocampus are formed by Kir6.1 subunits and SUR1 receptors. Mice with deficiencies in 
expression of either the SUR1 gene or the Kir6.1 gene are vulnerable to KA-induced seizures, an 
animal model of human temporal lobe epilepsy 9. Thus, expression of functional Kir6.1/SUR1 
channels can be considered as an endogenous cellular protective event against epileptic activity.  
Behaviorally observable seizures are induced by sustained, paroxysmal neuronal network 
activity due to the spreading of uncontrolled excessive glutamate synaptic transmission in the 
hippocampus 9. Consistent with this, our data show that release probability of glutamate at CA3 
synapses lacking the Kir6.1/SUR1 channels, but not the Kir6.2-containing channels, is increased 
during induction of epileptic form of seizures. Hence, expression of functional Kir6.1/SUR1 
channels is able to attenuate the danger of over-stimulation of glutamate transmission for 
generation of epileptic form of seizures. 
 The release of glutamate by pre-synaptic terminals is the initial event in generation of 
epileptic activity. The link between KA receptor activation and glutamate release is vague. Rise 
in intracellular Ca2+ concentration is a trigger for secretion as seen in insulin granules in the 
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pancreatic β-cells 63 and glutamate vesicle release in neuronal cells 117. In the presence of 
glucose, high concentrations of ATP inhibit the KATP channels. This depolarizes β-cell 
membranes opening voltage-gated Ca2+ channels (VDCC) 44. In pancreatic β-cells, Epac2, a 
cAMP dependent Guanine exchange factor interacts with the NB-1 domain of the SUR1 subunit. 
This interaction inhibits the KATP channel and increases insulin secretion.  
Similar to insulin secretion from β cells, glutamate release from pre-synaptic terminals is 
triggered by Ca2+ influx through VDCC, which is known to be regulated by Epac2 protein 
complex including Rim2 and Piccolo. Piccolo in addition can bind to the SUR1 receptors 118-120. 
It has been known that activation of KA receptors elevates cAMP levels 121;122, 123. Thus, 
application of KA may activate cAMP-dependent Epac2 in the Piccolo/SUR1/Kir6.1 channel 
complex and in turn regulate Ca2+-dependent glutamate release.  
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CHAPTER II 
AMPA RECEPTOR SUBUNIT GLUR2 GATES INJURIOUS  






Ischemic stroke is caused by occlusion of blood vessels supplying the brain and is the 
third leading cause of death in developed countries. A critical feature of brain injury following 
transient forebrain ischemic insult is a highly selective pattern of neuronal loss in the central 
nervous system (CNS). Certain identifiable subsets of neurons are severely damaged, including 
CA1 pyramidal neurons in the hippocampus, cortical projection neurons in layer 3, and medium 
spiny neurons in the dorsolateral striatum, whereas other neurons in the brain remain intact 32, 113, 
124. One step in this selective neuronal injury involves excessive stimulation of glutamate 
receptor (GluR) channels, allowing inflow of massive amounts of Ca2+, Zn2+, and Na+ in 
vulnerable neurons 125. Ca2+ overload can trigger several downstream lethal reactions, including 
nitrosative stress 126-130, oxidative stress 131, 132, and mitochondrial dysfunction133-136, as reviewed 
earlier125, 137 and represented in figure 15. The over stimulation of GluRs is the primary 
intracellular event that induces neuronal death. Therefore, synaptic GluR channels have been 































































CA1 pyramidal neurons degenerate 3 to 6 days after transient forebrain ischemia. The 
cellular events underlying this delayed neuronal injury involve three phases. Phase I: during an 
episode (approx 5 min) of forebrain ischemia, extracellular glutamate concentration in CA1 area 
of the hippocampus increases because of increased vesicle release or decreased re-uptake by the 
glutamate transporters. Ten minutes after ischemia, glutamate returns to the basal levels. Phase 
II: occurs 6 to 12 h after ischemia. A critical feature in this phase is the sustained changes of 
glutamate receptor channel activity, including: AMPA receptor channels become permeable to 
Ca2+ and NMDA receptor channel activity is enhanced. Subsequently, sustained Ca2+ inflow 
leads to mitochondria dysfunction and production of reactive oxygen species (ROS) and reactive 
nitrogen species (RNS). Phase III: about 48 h after ischemia, ultimately, the neuronal cell is 
damaged. 
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Glutamate toxicity in neuronal injury 
 
Glutamate plays an essential role in neural development, excitatory synaptic 
transmission, and plasticity 24, 139-143. Immediately following ischemia, however, glutamate 
accumulates at synapses 144-146, resulting in extensive stimulation of its receptors, which can 
eventually be neurotoxic 125, 137, 147, 148. Glutamate activates three classes of ionophore-linked 
postsynaptic receptors—namely, NMDA, AMPA and kainic acid receptors. NMDA receptor 
toxicity is dependent on extracellular Ca2+ and therefore, may reflect a large amount of Ca2+ 
influx directly through the receptor-gated ion channels 125, 137, 147-150. Because most AMPA 
receptor channels have poor Ca2+ permeability (with exceptions, as discussed later), injury may 
result primarily from indirect Ca2+ entry through Ca2+-permeable transient receptor potential  
channel member (TRPM)-7 channels127, Ca2+- permeable acid-sensing ion channels 151, and 
voltage-gated Ca2+ channels 152. Although excess stimulation of GluRs contributes to ischemic 
brain injury, blocking them completely could be deleterious to animals and humans because 
targeting these receptors would also block the physiological action of glutamate in noninjured 
neurons. Therefore, it may be fruitful to develop a practical approach whereby the pathological 
effects of glutamate in vulnerable neurons is selectively blocked, leaving the physiological action 




NMDA receptor channels in selective neuronal injury 
 
Glutamate toxicity largely results from NMDA receptor stimulation 125, 126, 137, 147, 148, 153. 
Knockout mice lacking the NMDA receptor NR2A gene show decreased cortical infarction after 
focal cerebral ischemia 154. Systemic administration of an NMDA receptor antagonist protects 
CA1 pyramidal neurons from ischemic injury 143, suggesting that activation of NMDA receptor 
channels following ischemia may mediate selective neuronal injury. However, these channels are 
widely expressed in many types of neurons, including ischemia-sensitive and -insensitive 
neurons in the CNS 155, 156. Therefore, certain pathological signaling molecules that modulate 
NMDA receptor function in vulnerable CA1 neurons may contribute to selective neuronal loss in 
the hippocampus of rats following transient forebrain ischemia 113. NMDA receptor channels are 
heteromeric complexes consisting of an essential NR1 subunit and one or more regulatory NR2 
subunits, NR2A-D 24, 155, 156. It was recently discovered that transient forebrain ischemia causes 
phosphorylation of NR2A at serine-1232 (phospho- Ser1232) in rat CA1 neurons in vivo 113. It 
was also determined that cyclin-dependent kinase 5 (Cdk5) catalyzes Ser1232 phosphorylation 
and that expression of a C-terminal peptide fragment of NR2A inhibits endogenous Cdk5 (or 
perturbs the Cdk5-NR2A interaction), thereby abolishing Ser1232 phosphorylation and 
protecting CA1 pyramidal neurons from ischemic insult 113. In addition, Cdk5-mediated 
regulation of NMDA receptor channels occurs only in CA1 neurons and not in other areas of the 
hippocampus. This shows that the covalent modification of NMDA receptors by Cdk5 is an 
essential intracellular event that determines vulnerability of neurons to the insult 113. Therefore, 
endogenous Cdk5 can be considered a suitable target regarding modification of cell survival 
during disease. 
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Expression of Ca2+-Permeable AMPA receptors in vulnerable CA1 pyramidal 
neurons 
 
Activation of endogenous Cdk5 depends on Ca2+ entry through AMPA receptors 113, 
which constitute a major GluR subtype 139, 141, 142, 144, 146. Functional AMPA receptor channels are 
assembled from GluR subunits 1 through 4 139, 141, 142, 144, 146. The Ca2+ permeability of AMPA 
receptor channels is determined by the GluR2 subunit 28, 29, 157-162. In the adult CNS, nearly 100% 
of the messenger RNA (mRNA) encoding GluR2 is edited at the Q/R site corresponding to 
residue 607, where the genomic glutamine (Q607) codon is converted to an arginine (R) codon 
(Figure 16) 28, 157-159, 161, 162. Edited GluR2(R) subunits form Ca2+-impermeable channels, whereas 
unedited GluR2(Q) channels allow Ca2+ entry 28, 29, 157-162 (Figure 16). 
 
Genomic Codon-607 (CAG) mRNA Codon-607 (CIG)
RNA editing
M1 M2 M3 M4
••SLGAFMQQG••




M1 M2 M3 M4
••SLGAFMQQG••




Figure 16. GluR2 gene is edited at the Q/R site 
 
 
GluR2 gene is edited at the genomic glutamine codon (Q607). This changes the 
aminoacid to an arginine forming Ca2+ impermeable GluR2(R) AMPA channels. During 
ischemia, this RNA editing is disrupted causing increased expression of GluR2(Q) AMPA 
channels that are permeable to Ca2+. This Ca2+ leads to excitotoxicity and cell death. 
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In most CA1 neurons, AMPA receptor channels contain the GluR2(R) subunits and, 
therefore, are impermeable to Ca2+ entry 29. A recent study showed that transient forebrain 
ischemia reduces GluR2 mRNA levels in hippocampal CA1 neurons 110. This observation led to 
the “GluR2 hypothesis,” which postulates that reduced GluR2 expression allows Ca2+ entry 
through AMPA receptor channels, which, in turn, induces CA1 pyramidal cell death 110, 163-165. 
The GluR2 hypothesis was proposed based on a causal relationship between CA1 pyramidal cell 
injury and reduced GluR2 gene expression following transient forebrain ischemia 164, 165. 
Therefore, it is important to understand whether a decrease of GluR2 mRNA actually causes 
AMPA receptor channels in vulnerable CA1 pramidal neurons to become permeable to Ca2+ 
entry. Ca2+ indicator dyes can be used to estimate AMPA receptor-mediated Ca2+ transients in 
CA1 pyramidal neurons. Indeed, an earlier work demonstrated that AMPA caused a large rise of 
intracellular Ca2+ in postischemic neurons compared to nonischemic control neurons 164. Recent 
studies involving whole-cell patch clamp recordings in individual CA1 pyramidal neurons from 
the rat hippocampus (visualized with infrared illumination and differential interference contrast 
(DIC, infrared- DIC) optics systems) 113 32 showed that AMPA receptors containing GluR2(R) 
exhibit inward currents with high extra cellular Na+, but not high Ca2+. In contrast receptors 
lacking GluR2(R) showed large inward currents with either high Na+ or Ca2+ 32. These data 
allowed for the determination of the permeability of AMPA receptor channels to Ca2+ (PCa/PNa) 
by calculating the shift in reversal potentials of AMPA receptor-mediated excitatory postsynaptic 
currents (EPSCsAMPA) when the extra cellular solution was switched from high Na+ to high Ca2+. 
Using this electrophysiological approach, it was also estimated that the Ca2+ permeability of 
AMPA receptor channels in CA1 pyramidal neurons of rats 12 h after transient global ischemia 
was 18-fold greater than that in sham controls. These data demonstrate that transient forebrain 
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ischemia induces AMPA receptor channels permeable to Ca2+ entry into vulnerable CA1 
pyramidal cells.  
 
Transcriptional regulation of GluR2 expression in CA1 neurons 
 
Cell-survival-related gene expression has its basis in signaling cascades initiated by the 
transcription factor Cyclic adenine monophospate Response Element Binding protein (CREB) 
166-169, which is believed to regulate GluR2 promoter activity 170. Therefore, CREB activation 
must stimulate the expression of the GluR2 gene and in turn, inhibit GluR2- gated injurious 
signals in vulnerable CA1 neurons 32. Accordingly, when a  constitutively active CREB, VP16-
CREB, was expressed in the rat CA1 pyramidal neurons in vivo 32 it inhibited Ca2+-permeable 
AMPA receptor channels in vulnerable CA1 pyramidal neurons following transient forebrain 
ischemia. Although the exact nature of the CREB signals for neuronal survival remains to be 
determined, expression of GluR2(R) may be one of the CREB pathways responsible for neuronal 
survival, because the protective role of CREB is abolished by directly introducing unedited 
GluR2(Q) gene 32. Therefore, on one hand, CREB increases GluR2 gene expression, thereby 
increasing the relative level of GluR2(R). The finding that CREB induces expression of brain-
derived neurotrophic factor (BDNF) supports this hypothesis 171, 172. BDNF binds to the GluR2 
promoter that contains the gene silencing transcription factor neuronal repressor element-1 
silencing transcription factor (REST)/neuron-restrictive silencer element (NRSE). Additionally, 
it was reported that forebrain ischemia induces expression of REST and, in turn, reduces GluR2 
gene expression 173. Importantly, acute knockdown of the REST gene rescues postischemic 
neurons from ischemia-induced cell death 173. Therefore, BDNF probably disrupts the interaction 
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of REST/NRSE with the GluR2 promoter, thus stimulating GluR2 gene expression 170. On the 
other hand, CREB activation may directly facilitate Q/R site editing of GluR2 mRNA, because 
increased mRNA editing also increases GluR2 mRNA levels by reducing nuclear accumulation 
of incompletely processed primary transcripts 174. 
 
Inhibition of Ca2+-permeable AMPA receptor channels protects vulnerable 
neurons from forebrain ischemic insult 
 
Transient forebrain ischemia induces expression of Ca2+-permeable AMPA receptor 
channels in vulnerable CA1 neurons, which then activates a series of intracellular injurious 
signals 113. To investigate this possibility, it is necessary to selectively block Ca2+ permeability of 
AMPA receptor channels in rat CA1 vulnerable neurons in vivo. An early work reported that 
administration of Naspm, an open-channel blocker selective for Ca2+-permeable AMPA receptor 
175, 176, reduced GluR2 antisense-induced cell death and suggested that cell death induced by 
multiple injections of GluR2 antisense was mediated by Ca2+-permeable AMPA receptors 163. 
Recently, virus-based gene expression vectors was used to introduce the GluR2(R) gene that is 
independent of Q/R site editing into the adult rat hippocampus in vivo. Using whole-cell patch 
clamp recordings, Liu S et al., obtained direct evidence that introduction of the GluR2(R) gene 
selectively inhibits Ca2+ permeability of AMPA receptor channels occurring in vulnerable CA1 
pyramidal neurons of adult rats following transient forebrain ischemia 32. This study provides the 
first direct evidence that selective inhibition of Ca2+ permeability of AMPA receptor channels 
rescues CA1 pyramidal neurons from forebrain ischemic insult 32.  
In contrast to CA1 pyramidal neurons, granule neurons in the hippocampus are 
insensitive to ischemic injury 32, 113, 124, and AMPA receptor channels in these cells are Ca2+-
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impermeable. To further demonstrate whether expression of Ca2+-permeable AMPA receptor 
channels determine vulnerability of neurons to the insult, the granule cells were engineered to 
express Ca2+-permeable GluR2(Q) channels by direct introduction of exogenous unedited 
GluR2(Q) gene into the adult hippocampus. Following this manipulation, it was found that the 
granule neurons degenerate following transient global ischemia 32. Similarly to these results 
observed upon expression of unedited GluR2(Q) gene, a recent report showed that delivery of 
GluR2(Q) complementary DNA into the hippocampus by a liposome-mediated gene transfer 
increases the sensitivity of neurons in the hippocampus to forebrain ischemia insult 177. Together, 
it is suggested that the expression of Ca2+-permeable AMPA receptor channels provides a route 
for toxic Ca2+ entry, which then triggers neuronal cell death in the hippocampus 178-182. Ca2+-
permeable AMPA receptor channels are not only permeable to Ca2+ but are also highly 
permeable to Zn2+ 178-182 and that a brief ischemic insult in rats induces Zn2+ accumulation in 
vulnerable neurons 183, 184. Therefore, Ca2+/Zn2+ influx can be considered an initial event for 
activation of an array of downstream enzymes that degrade membranes and proteins essential for 
cellular integrity, as illustrated in Fig. 15. Thus, recent results demonstrate that expression of the 
GluR2(R) gene blocks Ca2+ entry through AMPA receptor channels and prevents activation of 
endogenous Cdk5 in vulnerable CA1 neurons 32, 113. Furthermore, Cdk5 activation causes the 
sustained opening of NMDA receptor channels, resulting in an intracellular Ca2+ overload. Taken 
together these date leads to a model where GluR2-gated intracellular signaling cascade 
determines selective neuronal vulnerability after forebrain ischemia, as described in Fig. 17. 
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Figure 17.  Induction of Ca2+-permeable AMPA receptor channels primes cell death. 
 
 
AMPA receptor channels in CA1 pyramidal neurons normally contain an edited form of 
GluR2 subunit (GluR2[R]) and, therefore, are Ca2+ impermeable. Following transient forebrain 
ischemia, GluR2(R) levels in CA1 neurons decreases, resulting in Ca2+ entry through AMPA 
receptor channels. The subsequent p25 accumulation leads to prolonged activation of Cdk5, 
which phosphorylates the NR2A subunit of NMDA receptors at Ser1232 and induces further 
























 Ca2+ permeable AMPA channel expression is increased during 
 transient forebrain ischemia 
 
Delivery of GluR2 proteins from intracellular pools to the cell surface is required for 
expression of functional AMPA receptor channels at CA1 synapses184, 185 as illustrated in Fig. 
18.. So here we hypothesize that reduced GluR2 expression during an ischemic insult will reduce 
the expression of functional AMPA channels on the cell surface. To test this hypothesis, we 
performed electrophysiological analysis on CA1 synapses during an ischemic insult. We also 






Figure 18.  Surface expression of GluR2 subunit is increased during ischemia 
 
The illustration shows GluR2-dependent translocation of GluR1/GluR2 receptor channels 
at CA1 synapses. GluR1 is unable to incorporate into cell surface without GluR2.
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Materials and methods 
 
Transient forebrain ischemia 
 
Transient forebrain ischemia was induced in rats as described before 31. Briefly, 80 ± 5-
day-old Sprague Dawley rats were used. The bilateral vertebral arteries were exposed, 
coagulated and cut completely 12 hr before the induction of ischemia. Ischemia was induced by 
bilaterally occluding the common carotid arteries with aneurysm clips for 15 mins, after which 
the clips were removed to restore cerebral blood flow. Body temperature was maintained at 37ºC 
with heating pads until the animals had recovered from surgery. Sham-operated animals were 
treated identically, except that the carotid arteries were not occluded. The brain was extracted 
from these animals 12h later and processed for electrophysiology recordings or protein extraction 




Sample traces of miniature EPSCsAMPA taken from CA1 pyramidal neurons in 
hippocampal slices from rats 12 h after sham or transient forebrain ischemia. Hippocampal slices 
(250 µm) were prepared from mice, as described before 31, 32, 113. Slices in the recording chamber 
were continuously perfused with artificial cerebrospinal fluid (ACSF, 2 ml/min) saturated with 
95% O2/5% CO2 at 30°C ± 1°C. The composition of ACSF was 124 mM NaCl, 3 mM KCl, 1.25 
mM NaH2PO4, 1.2 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, and 10 mM dextrose. For whole-
cell patch-clamp recordings (tight seal >15-25 GΩ) from CA3 pyramidal cells, hippocampal 
slices were visualized with IR-DIC optics with an Axioskop 2FS equipped with Hamamatsu 
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C2400-07E optics. The spontaneous EPSCs were recorded at a holding potential of -70 mV. The 
intracellular solution contained 142.5 mM Cs-gluconate, 7.5 mM CsCl, 10 mM HEPES, 0.2 mM 
EGTA, 2 mM Mg-ATP, 0.3 mM guanosine triphosphate (pH 7.4; 296 mOsm), 50 µM of AP5, 10 
µM of Bicucculline. The currents were filtered at 5 kHz with a low-pass filter. Data were 
digitized at a frequency of 10 kHz and stored online with the pclamp11 system (Axon 
Instruments, Inc., Foster, CA). The input resistance and series resistance in postsynaptic 
pyramidal cells were monitored with prevoltage steps (−2 mV; 100 ms) at 5 min intervals 
throughout the period of the experiment. Series resistance ranged from 11 to 17 MΩ. Input 
resistance was 346 ± 18 MΩ. Data are mean ± SEM (n = 8 cells/four animals) 
 
Detection of GluR2 protein levels 
 
The CA1 extracts (20 µg of protein) was obtained from rats 6h and 12h after they 
underwent transient forebrain ischemia or sham. It was denatured with sodium dodecyl sulfate 
sample buffer, separated by SDS-PolyAcrylamide Gel Electrophoresis on a 12% gel, transferred 
into nitrocellulose membranes, and incubated with rabbit anti-GluR1 (1:500; Chemicon), anti-
GluR2 (1:200; Santa Cruz), anti-GluR3 (1: 200; Santa Cruz), antiGluR4 (1:500; Santa Cruz) and 
anti-α-actin (1:1000; Chemicon). Immunoreactive bands were detected using an enhanced 
Chemiluminescent kit (Amersham Biosciences) and quantified using Densitometer Quantity One 
(Bio-Rad). Each reactive band was normalized to its respective sham (defined as 1.0). Data are 




The numbers of functional AMPA channels do not change during ischemia 
 
The electrophysiological recordings of the miniature EPSCsAMPA from CA1 pyramidal 
neurons revealed that the mean amplitude of the miniature EPSCsAMPA in rats that were subjected 
to transient forebrain ischemia was the same as that in sham animals (Fig. 19 a and b). These 
results are consistent with previous reports that, although AMPA receptor channels are 
permeable to Ca2+ 32, 113, 186, the EPSCsAMPA are not reduced 187, 188. Because two distinct 
GluR1/GluR2 and GluR3/GluR2 channels are located in CA1 pyramidal neurons 189-191, 
unchanged amplitudes of synaptic responses following reduced GluR2 gene expression could 








Figure 19. The mean amplitude of miniature EPSCsAMPA remain unchanged in CA1 















a) Sample traces of miniature EPSCsAMPA taken from CA1 pyramidal neurons in 
hippocampal slices from rats 12 h after sham or transient forebrain ischemia. b) Averaged traces 
of the miniature EPSCsAMPA from (a) are shown on the top. The mean amplitudes (pA) of the 
responses are summarized in bar graph.  
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GluR2 protein level is reduced by transient forebrain ischemia 
 
We analyzed protein levels of AMPA receptor subunits in CA1 area of the hippocampus 
from rats 12 h after transient forebrain ischemia. Western blots demonstrated that the GluR2 
proteins in CA1 dorsal hippocampus were reduced by 38.8 ± 4.9% (n = 6; Fig. 20) compared to 
sham control rats. Unlike the GluR2 subunit, protein levels of GluR1, GluR3, and GluR4 





Figure 20. GluR2 proteins in CA1 hippocampus is reduced following transient forebrain 
ischemia. 
 
a) Representative Western blots of the CA1 cell lysates blotted with the indicated 




 The GluR2 subunit is a requisite for AMPA channel expression on the neuronal cell 
surface. Hence, reduced GluR2 protein levels mean less number of channels on the cell 
surface. However, this study shows that the amplitude of current flowing through the 
AMPA receptors does not change during transient ischemia. This means the number of 
functional AMPA channels do not change because of the ischemic insult.  
 Previous data shows that when GluR2 Q/R site editing is impaired the unedited 
transcripts accumulate in the nucleus reducing expressed GluR2 protein levels. Also, the 
Ca2+/Zn2+ permeability of AMPA receptor channels is blocked by GluR2(R) Ca2+-
impermeable AMPA receptor channels, whereas the unedited GluR2(Q) allows Ca2+ 
entry through the channels. This study also shows that transient forebrain ischemia 
reduces GluR2 protein levels. As the number of functional AMPA channels on the cell 
surface is not reduced, we suggest that transient forebrain ischemia impairs GluR2 pre-
mRNA editing hence decreasing the number of unedited GluR2 transcripts and total 
GluR2 protein levels. This increases the number of GluR2 (Q) channels on the cell 






The Ca2+/Zn2+ permeability of AMPA receptor channels is dominated by the GluR2 
subunit; an edited GluR2(R) forms Ca2+-impermeable AMPA receptor channels, whereas the 
unedited GluR2(Q) allows Ca2+ entry through the channels 28, 29, 157-159, 161, 162. Accordingly, 
expression of Ca2+/Zn2+-permeable AMPA receptor channels in vulnerable CA1 neurons 
following transient forebrain ischemia can simply result from reduced GluR2 gene expression, as 
described earlier. Notably, delivery of GluR2 proteins from intracellular pools to the cell surface 
is required for expression of functional AMPA receptor channels at CA1 synapses184, 185. 
Therefore, reduction of GluR2 protein levels should decrease the numbers of functional AMPA 
receptor channels, as illustrated in Fig. 18a. 
However, electrophysiological recordings of the miniature EPSCsAMPA from CA1 
pyramidal neurons revealed that the mean amplitude of the miniature EPSCsAMPA in rats that 
were subjected to transient forebrain ischemia was the same as that in sham animals (Fig. 18 b 
and c). These results are consistent with previous reports that, although AMPA receptor channels 
are permeable to Ca2+ 32, 113, the EPSCsAMPA are not reduced 187, 188. Because two distinct 
GluR1/GluR2 and GluR3/GluR2 channels are located in CA1 pyramidal neurons 189-191, 
unchanged amplitudes of synaptic responses following reduced GluR2 gene expression could 
result from over expression of GluR1 and GluR3 subunits. 
To address this question, we analyzed protein levels of AMPA receptor subunits in CA1 
area of the hippocampus from rats after transient forebrain ischemia. Western blots demonstrated 
that the GluR2 proteins in CA1 dorsal hippocampus were reduced while the GluR1, GluR3, and 
GluR4 subunits protein levels was not changed. Together, we suggest that transient forebrain 
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ischemia facilitates the events for incorporation of GluR2 subunits to plasma membrane. Under 
this circumstance, although GluR2 gene expression is reduced, the numbers of functional AMPA 
receptor channels remain unchanged.  
Previous studies revealed that Q/R site unedited GluR2 easily exits the endoplasmic 
reticulum and becomes the cell surface receptor channels 192, 193. These findings implicate that 
pre-mRNA editing of GluR2 at Q/R site could be impaired in vulnerable CA1 pyramidal neurons 
following transient forebrain ischemia. Consistent with this hypothesis, recent studies have 
demonstrated that impaired Q/R site editing contributes to selective motor neuronal death in 
patients with amyotrophic lateral sclerosis 194, 195. Gene-targeting studies demonstrated that the 
deficits of GluR2 pre-RNA editing at Q/R site reduced GluR2 mRNA levels because of nuclear 
accumulation of incompletely processed primary GluR2 transcripts 185. Therefore, reduced 
GluR2 mRNA levels observed in the CA1 area of the rat hippocampus following transient 
forebrain ischemia may result from reduced Q/R site editing of GluR2 pre-mRNA. To address 
this question, it is necessary to use single-cell reverse transcriptase polymerase chain reaction to 
estimate GluR2 Q/R editing versus pre-mRNA accumulation in the nucleus of individual neurons 
in the rat hippocampus. 
To date, all clinical stroke trials targeting GluRs (AMPA or NMDA) have failed, possibly 
because receptor antagonists also block the physiological actions of glutamate in uninjured 
neurons 196, 197. This work outlines a potential approach to selectively block the pathological 
effects of AMPA receptors by targeting GluR2 subunit, thereby inhibiting only Ca2+/Zn2+ 
permeability. Thus, this approach should not affect the physiological actions of Ca2+/Zn2+-
impermeable AMPA receptors in uninjured neurons in the CNS. Therefore, this work may define 
a promising target for stroke therapy. As reported 194, 195, a defect in GluR2 editing also 
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contributes to motor neuron death in amyotrophic lateral sclerosis. It is probable that a similar 
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